Format

Send to

Choose Destination
Hepatology. 2016 Sep;64(3):966-76. doi: 10.1002/hep.28493. Epub 2016 Apr 4.

Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.

Author information

1
Department of Integrated OMICS for Biomedical Science, Graduate School, Yonsei University, Seoul, Korea.
2
Department of Internal Medicine III and IZKF, University Hospital Aachen, Aachen, Germany.
3
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
4
Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI.
5
Department of Medicine, University of Michigan Medical School, Ann Arbor, MI.
6
VA Ann Arbor Health Care System, Ann Arbor, MI.

Abstract

Keratins, formerly known as cytokeratins, are the major epithelial-specific subgroup of intermediate filament proteins. Adult hepatocytes express keratin polypeptides 8 and 18 (K8/K18), whereas cholangiocytes express K8/K18 and keratins 7 and 19 (K7/K19). Keratins function primarily to protect hepatocytes from apoptosis and necrosis, which was revealed using several genetic mouse models. This cytoprotective function was further clarified by the identification of natural human keratin variants that are normally silent, but become pathogenic by predisposing their carriers to apoptosis during acute or chronic liver injury mediated by toxins, virus infection, or metabolic stress. During apoptosis, caspases cleave K18 and K19 at conserved aspartates (human K18/K19: (235) Val-Glu-Val-Asp(↓) ) and K18 at a unique aspartate (human K18: (394) Asp-Ala-Leu-Asp(↓) ), with the latter exposed epitope becoming recognized by the M30 antibody in blood and tissues. Additional K18-containing protein backbone epitopes are detected using the M6 and M5 (termed M65) antibodies. Intact K18 and its associated fragments, which are released into blood during apoptosis and necrosis in various diseases, have been analyzed by enzyme-linked immunosorbent assay using the M30/M65 antibodies or their signal ratios. Furthermore, M30/M65 levels have been used as diagnostic and prognostic biomarkers in acute and chronic liver diseases, including nonalcoholic steatohepatitis and acute liver failure. Other keratin biomarkers include K8/K18/K19-related tissue polypeptide antigen, K18-related tissue polypeptide-specific antigen, and K19-related CYFRA-21-1, which have been evaluated mostly in patients with epithelial tumors.

CONCLUSION:

Keratins and their fragments are released into blood during liver and other epithelial tissue injury. The epithelial specificity of K18/K19, epitope unmasking upon caspase digestion, keratin abundance, and relative keratin stability render them useful biomarkers for hepatocyte and cholangiocyte apoptosis and necrosis. However, the precise biochemical nature and release mechanism of circulating keratins remain unknown. (Hepatology 2016;64:966-976).

PMID:
26853542
PMCID:
PMC4977204
DOI:
10.1002/hep.28493
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center